| Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis 2021 · Ashwagandha · Health care workers engaged in combatting COVID-19; adults, with mean age 38.38 years in the interim group | 500 mg | 16 weeks | 80 |
| Safety and Efficacy of Ashwagandha Root Extract on Cognition, Energy and Mood Problems in Adults: Prospective, Randomized, Placebo-Controlled Study 2026 · Ashwagandha root extract (ARE) · Healthy adults aged 30–75 years with self-reported cognitive and energy problems | 600 mg | 8 weeks | 60 |
| Efficacy and safety of Ashwagandha (Withania somnifera) root extract on stress and weight management in adults: a prospective, randomized, double-blind, placebo-controlled study 2025 · ARE group · Men and women aged 19–65 years with overweight or obesity (BMI 25.0–39.9 kg/m²) | 600 mg | 180 days | 50 |
| Effects of Ashwagandha ( Withania somnifera) standardized root extract on physical endurance and VO (2max) in healthy adults performing resistance training: An eight-week, prospective, randomized, double-blind, placebo-controlled study 2023 · AG (Ashwagandha) group · Healthy, physically active adults aged 18–45 years, men and women, undertaking regular resistance training | 600 mg | 8 weeks | 40 |
| Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study 2018 · WSE · Patients with schizophrenia or schizoaffective disorder experiencing an exacerbation of symptoms | 1 g | 12 weeks | 33 |
| Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial 2024 · WS500 group · Adults aged 18–60 with chronic-stress-related anxiety, depression, and/or sleep disturbance for more than 3 months and elevated Perceived Stress Scale scores | 500 mg | 8 weeks | 31 |
| Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Improving Sexual Function in Women: A Pilot Study 2015 · HCARE-treated group (Group A) · Women aged 21–50 with female sexual dysfunction, including hypoactive sexual desire disorder, female sexual arousal disorder, female orgasmic disorder, or combined genital and subjective arousal disorder | 600 mg | 8 weeks | 25 |
| Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial 2015 · Ashwagandha group · Healthy men aged 18–50 undergoing resistance training | 600 mg | 8 weeks | 25 |
| A double-blind, randomized, placebo-controlled trial on the effect of Ashwagandha (Withania somnifera dunal.) root extract in improving cardiorespiratory endurance and recovery in healthy athletic adults 2021 · Ashwagandha group · Healthy athletic adults | 600 mg | 8 weeks | 25 |
| Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder 2013 · WSE · Euthymic adults with DSM-IV bipolar disorder receiving maintenance medication | 500 mg | 8 weeks | 24 |
| Assessment of the Efficacy of Withania somnifera Root Extract in Patients with Generalized Anxiety Disorder: A Randomized Double-blind Placebo- Controlled Trial 2021 · W. somnifera extract group · Patients with confirmed generalized anxiety disorder receiving selective serotonin reuptake inhibitors | 1 g | 6 weeks | 22 |
| Effects of Root Extract of Ashwagandha (Withania somnifera) on Perception of Recovery and Muscle Strength in Female Athletes 2025 · ASH · Female professional footballers aged 18–36, healthy and free of disease | 600 mg | 4 weeks | 15 |
| Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled Trial 2017 · Ashwagandha · Adults under chronic stress | 600 mg | 8 weeks | — |
| Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions 2017 · Ashwagandha-root extract group · Adults with mild cognitive impairment; age and sex not specified | 600 mg | 8 weeks | — |
| Effects of an Aqueous Extract of Withania somnifera on Strength Training Adaptations and Recovery: The STAR Trial 2018 · Ashwagandha (S500) group · Apparently healthy, recreationally active men aged 18–45 years | 500 mg | 12 weeks | — |
| A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males 2019 · Ashwagandha period · Healthy overweight males aged 40–70 years with mild-to-moderate self-reported fatigue or reduced vitality | 600 mg | 8 weeks | — |
| Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study 2021 · Ashwagandha root extract · Women with climacteric symptoms during perimenopause | 600 mg | 8 weeks | — |
| The Perceived Impact of Ashwagandha on Stress, Sleep Quality, Energy, and Mental Clarity for College Students: Qualitative Analysis of a Double-Blind Randomized Control Trial 2022 · intervention group · College students aged 18–50 years | 700 mg | 30 days | — |
| The Impact of Ashwagandha on Stress, Sleep Quality, and Food Cravings in College Students: Quantitative Analysis of a Double-Blind Randomized Control Trial 2022 · Ashwagandha group · Healthy college students; age and sex not specified | 700 mg | 30 days | — |
| Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial 2023 · ashwagandha · Men and women aged 40–75 years with BMI 25–35, low energy, fatigue, and moderate-to-high stress | 400 mg | 12 weeks | 60 |
| Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial 2024 · WS250 group · Adults aged 18–60 with chronic-stress-related anxiety, depression, and/or sleep disturbance for more than 3 months and elevated Perceived Stress Scale scores | 250 mg | 8 weeks | 33 |
| Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial 2023 · Ayurveda group (AG) · People with mild or moderate COVID-19; age and sex not reported | 500 mg | 15 days | 25 |
| Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study 2025 · Somin-On™ group · Adults with mild cognitive impairment (MCI); age and sex not specified | 250 mg | 60 days | 20 |
| A New Ashwagandha Formulation (Zenroot™) Alleviates Stress and Anxiety Symptoms While Improving Mood and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Clinical Study 2025 · ZEN (Zenroot™) group · Adults aged 18–55, male and female, with non-chronic mild-to-moderate stress | 125 mg | 12 weeks | 45 |
| Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial 2024 · WS125 group · Adults aged 18–60 with chronic-stress-related anxiety, depression, and/or sleep disturbance for more than 3 months and elevated Perceived Stress Scale scores | 125 mg | 8 weeks | 34 |
| An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study 2019 · ashwagandha group · Healthy male and female adults aged 18–65 years with mild stress (HAM-A score 6–17) | 240 mg | 60 days | 30 |
| Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood 2024 · ashwagandha (ASH) group · Healthy men and women aged 18–49 years (study eligibility 18–60), without diagnosed cognitive deficits or the listed exclusions | 225 mg | 30 days | 30 |
| Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial 2016 · treatment group · Adults with confirmed obsessive-compulsive disorder receiving SSRIs; age and sex not stated | 120 mg | 6 weeks | 15 |
| A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults 2020 · Ashwagandha group · Healthy adults with high non-restorative sleep measures; age and sex not stated | 120 mg | 6 weeks | — |
| Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients 2021 · Treatment Arm · Patients aged 15–80 with asymptomatic or mild COVID-19, positive by RT-PCR; non-pregnant women, with no stated major comorbidities | 1 g | 7 days | 45 |
| Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974 2009 · Naturopathic Care (NC) · Adult Canada Post employees with moderate or greater anxiety; women and men, mean age about 52 years | 600 mg | 12 weeks | 41 |
| A Standardized Withania somnifera (Linn.) Root Extract with Piperine Alleviates the Symptoms of Anxiety and Depression by Increasing Serotonin Levels: A Double-Blind, Randomized, Placebo-Controlled Study 2024 · ARE · Individuals with mild to moderate depression and anxiety | 500 mg | 90 days | 34 |
| A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life in healthy adults by modulating stress hormones: Results from a randomized, double-blind, placebo-controlled study 2023 · ARE (Ashwagandha root extract) · Adults aged 21–54 years with mild-to-moderate stress and anxiety, without chronic disease | 500 mg | 60 days | 27 |
| Superior Bioavailability of a Novel 1.5% Ashwagandha Formulation (Zenroot™): A Randomized, Double-Blind, Single-Dose, Comparative, Oral Bioavailability Study in Healthy Adults 2025 · ASH 5 (Ashwagandha 5%) · Healthy adults aged 18–55 years, male and female | 600 mg | 1 day | 18 |
| Superior Bioavailability of a Novel 1.5% Ashwagandha Formulation (Zenroot™): A Randomized, Double-Blind, Single-Dose, Comparative, Oral Bioavailability Study in Healthy Adults 2025 · ASH 10 (Ashwagandha 10%) · Healthy adults aged 18–55 years, male and female | 500 mg | 1 day | 14 |
| Ashwagandha Root Extract Stabilises Physiological Stress Responses in Male and Female Team Sports Athletes During Pre-Season Training 2026 · Ashwagandha (ASH) group · Healthy male and female semi-professional team-sport athletes aged 18–35 years | 600 mg | 6 weeks | 28 |
| Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial 2018 · Ashwagandha treatment group · Adults aged 18–50 with subclinical hypothyroidism and elevated serum TSH levels (4.5–10 μIU/L) | 600 mg | 8 weeks | 25 |
| Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial 2023 · ashwagandha · Men aged 40–75 years with BMI 25–35, low energy, fatigue, and moderate-to-high stress | 400 mg | 12 weeks | 28 |
| Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial 2023 · ashwagandha · Women aged 40–75 years with BMI 25–35, low energy, fatigue, and moderate-to-high stress | 400 mg | 12 weeks | 24 |
| Effects of Withania somnifera in patients of schizophrenia: a randomized, double blind, placebo controlled pilot trial study 2013 · Withania somnifera extract (WSE) · Adults with schizophrenia receiving second-generation antipsychotics for at least 6 months and metabolic syndrome criteria | 1.2 g | 30 days | 15 |
| Superior Bioavailability of a Novel 1.5% Ashwagandha Formulation (Zenroot™): A Randomized, Double-Blind, Single-Dose, Comparative, Oral Bioavailability Study in Healthy Adults 2025 · ZEN 1.5 (Ashwagandha 1.5%) · Healthy adults aged 18–55 years, male and female | 125 mg | 1 day | 18 |
| Comparative evaluation of the effects of Withania somnifera with pentoxifylline on the sperm parameters in idiopathic male infertility: A triple-blind randomised clinical trial 2018 · W. somnifera group · Male patients with idiopathic infertility; age range not reported | 5 g | 90 days | — |